Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: A preliminary report
To describe the changes in demographics, antidiabetic treatment, and glycemic control among the prevalent U.S. adult diagnosed type 2 diabetes population between the National Health and Nutrition Examination Survey (NHANES) III (1988-1994) and the initial release of NHANES 1999-2000. The study popul...
Gespeichert in:
| Veröffentlicht in: | Diabetes care 2004, Vol.27 (1), p.17-20 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 20 |
|---|---|
| container_issue | 1 |
| container_start_page | 17 |
| container_title | Diabetes care |
| container_volume | 27 |
| creator | KORO, Carol E BOWLIN, Steven J BOURGEOIS, Nancy FEDDER, Donald O |
| description | To describe the changes in demographics, antidiabetic treatment, and glycemic control among the prevalent U.S. adult diagnosed type 2 diabetes population between the National Health and Nutrition Examination Survey (NHANES) III (1988-1994) and the initial release of NHANES 1999-2000.
The study population was derived from NHANES III (n = 1,215) and NHANES 1999-2000 (n = 372) subjects who reported a diagnosis of type 2 diabetes with available data on diabetes medication and HbA(1c). Four therapeutic regimens were defined: diet only, insulin only, oral antidiabetic drugs (OADs) only, or OADs plus insulin. Multiple logistic regression was used to examine changes in antidiabetic regimens and glycemic control rates over time, adjusted for demographic and clinical risk factors. The outcome measure for glycemic control was HbA(1c). Glycemic control rates were defined as the proportion of type 2 diabetic patients with HbA(1c) level |
| doi_str_mv | 10.2337/diacare.27.1.17 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_80071790</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A112312321</galeid><sourcerecordid>A112312321</sourcerecordid><originalsourceid>FETCH-LOGICAL-g314t-69884ce3be3cfff9120c63c3d9531ba227d86291bba47194bebf70e1bdf848a63</originalsourceid><addsrcrecordid>eNptkM1r3DAQxUVoaTZJz70VXdqbXX3ZlnpbQpsUAj00ORtJHjkqsuVKWsL-91XIll7CDAw8fjNveAh9oKRlnA9fJq-tTtCyoaUtHc7QjireNV0n5Bu0I1SoplOKnaOLnH8TQoSQ8h06p6JXXPVkh_xNOFpYvMU2riXFgF2KC6ZKSlwiZnUH6yWuM35of7VYT4dQMq628xozTPjJl0dcjhtg9qwaKJC_4j3eEgS_-FWnI06wxVSu0FunQ4b3p3mJHr5_u7--be5-3vy43t81M6eiNH11Fha4AW6dc4oyYntu-aQ6To1mbJhkzxQ1RouBKmHAuIEANZOTQuqeX6LPL3e3FP8cIJdx8dlCCHqFeMijJGSggyIVbF7AWQcY_epiSdrOsELSIa7gfJX3lDJem9HKt6_wtabn_F5d-Hj65GAWmMYt-aXmMf5LvwKfToDOVgeX9Gp9_s91XLJedvwvUrKSOQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80071790</pqid></control><display><type>article</type><title>Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: A preliminary report</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>KORO, Carol E ; BOWLIN, Steven J ; BOURGEOIS, Nancy ; FEDDER, Donald O</creator><creatorcontrib>KORO, Carol E ; BOWLIN, Steven J ; BOURGEOIS, Nancy ; FEDDER, Donald O</creatorcontrib><description>To describe the changes in demographics, antidiabetic treatment, and glycemic control among the prevalent U.S. adult diagnosed type 2 diabetes population between the National Health and Nutrition Examination Survey (NHANES) III (1988-1994) and the initial release of NHANES 1999-2000.
The study population was derived from NHANES III (n = 1,215) and NHANES 1999-2000 (n = 372) subjects who reported a diagnosis of type 2 diabetes with available data on diabetes medication and HbA(1c). Four therapeutic regimens were defined: diet only, insulin only, oral antidiabetic drugs (OADs) only, or OADs plus insulin. Multiple logistic regression was used to examine changes in antidiabetic regimens and glycemic control rates over time, adjusted for demographic and clinical risk factors. The outcome measure for glycemic control was HbA(1c). Glycemic control rates were defined as the proportion of type 2 diabetic patients with HbA(1c) level <7%.
Dietary treatment in individuals with diabetes decreased as the sole therapy from 27.4 to 20.2% between the surveys. Insulin use also decreased from 24.2 to 16.4%, while those on OADs only increased from 45.4 to 52.5%. Combination of OADs and insulin increased from 3.1 to 11.0%. Glycemic control rates declined from 44.5% in NHANES III (1988-1994) to 35.8% in NHANES 1999-2000.
Treatment regimens among U.S. adults diagnosed with type 2 diabetes have changed substantially over the past 10 years. However, a decrease in glycemic control rates was also observed during this time period. This trend may contribute to increased rates of macrovascular and microvascular diabetic complications, which may impact health care costs. Our data support the public health message of implementation of early, aggressive management of diabetes.</description><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/diacare.27.1.17</identifier><identifier>PMID: 14693960</identifier><identifier>CODEN: DICAD2</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>Administration, Oral ; Adult ; Aged ; Biological and medical sciences ; Blood Glucose - metabolism ; Care and treatment ; Demographic aspects ; Demography ; Diabetes Mellitus, Type 2 - blood ; Diabetes Mellitus, Type 2 - epidemiology ; Diabetes Mellitus, Type 2 - therapy ; Diabetes therapy ; Diabetes. Impaired glucose tolerance ; Diet, Diabetic ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Ethnic Groups ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Evaluation ; Health Surveys ; Humans ; Hypoglycemic Agents - administration & dosage ; Hypoglycemic Agents - therapeutic use ; Insulin - therapeutic use ; Medical sciences ; Middle Aged ; Risk Factors ; Type 2 diabetes ; United States</subject><ispartof>Diabetes care, 2004, Vol.27 (1), p.17-20</ispartof><rights>2004 INIST-CNRS</rights><rights>COPYRIGHT 2004 American Diabetes Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,4010,27904,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15382685$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14693960$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KORO, Carol E</creatorcontrib><creatorcontrib>BOWLIN, Steven J</creatorcontrib><creatorcontrib>BOURGEOIS, Nancy</creatorcontrib><creatorcontrib>FEDDER, Donald O</creatorcontrib><title>Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: A preliminary report</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><description>To describe the changes in demographics, antidiabetic treatment, and glycemic control among the prevalent U.S. adult diagnosed type 2 diabetes population between the National Health and Nutrition Examination Survey (NHANES) III (1988-1994) and the initial release of NHANES 1999-2000.
The study population was derived from NHANES III (n = 1,215) and NHANES 1999-2000 (n = 372) subjects who reported a diagnosis of type 2 diabetes with available data on diabetes medication and HbA(1c). Four therapeutic regimens were defined: diet only, insulin only, oral antidiabetic drugs (OADs) only, or OADs plus insulin. Multiple logistic regression was used to examine changes in antidiabetic regimens and glycemic control rates over time, adjusted for demographic and clinical risk factors. The outcome measure for glycemic control was HbA(1c). Glycemic control rates were defined as the proportion of type 2 diabetic patients with HbA(1c) level <7%.
Dietary treatment in individuals with diabetes decreased as the sole therapy from 27.4 to 20.2% between the surveys. Insulin use also decreased from 24.2 to 16.4%, while those on OADs only increased from 45.4 to 52.5%. Combination of OADs and insulin increased from 3.1 to 11.0%. Glycemic control rates declined from 44.5% in NHANES III (1988-1994) to 35.8% in NHANES 1999-2000.
Treatment regimens among U.S. adults diagnosed with type 2 diabetes have changed substantially over the past 10 years. However, a decrease in glycemic control rates was also observed during this time period. This trend may contribute to increased rates of macrovascular and microvascular diabetic complications, which may impact health care costs. Our data support the public health message of implementation of early, aggressive management of diabetes.</description><subject>Administration, Oral</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Blood Glucose - metabolism</subject><subject>Care and treatment</subject><subject>Demographic aspects</subject><subject>Demography</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Diabetes Mellitus, Type 2 - therapy</subject><subject>Diabetes therapy</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Diet, Diabetic</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Ethnic Groups</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Evaluation</subject><subject>Health Surveys</subject><subject>Humans</subject><subject>Hypoglycemic Agents - administration & dosage</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Insulin - therapeutic use</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Risk Factors</subject><subject>Type 2 diabetes</subject><subject>United States</subject><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkM1r3DAQxUVoaTZJz70VXdqbXX3ZlnpbQpsUAj00ORtJHjkqsuVKWsL-91XIll7CDAw8fjNveAh9oKRlnA9fJq-tTtCyoaUtHc7QjireNV0n5Bu0I1SoplOKnaOLnH8TQoSQ8h06p6JXXPVkh_xNOFpYvMU2riXFgF2KC6ZKSlwiZnUH6yWuM35of7VYT4dQMq628xozTPjJl0dcjhtg9qwaKJC_4j3eEgS_-FWnI06wxVSu0FunQ4b3p3mJHr5_u7--be5-3vy43t81M6eiNH11Fha4AW6dc4oyYntu-aQ6To1mbJhkzxQ1RouBKmHAuIEANZOTQuqeX6LPL3e3FP8cIJdx8dlCCHqFeMijJGSggyIVbF7AWQcY_epiSdrOsELSIa7gfJX3lDJem9HKt6_wtabn_F5d-Hj65GAWmMYt-aXmMf5LvwKfToDOVgeX9Gp9_s91XLJedvwvUrKSOQ</recordid><startdate>2004</startdate><enddate>2004</enddate><creator>KORO, Carol E</creator><creator>BOWLIN, Steven J</creator><creator>BOURGEOIS, Nancy</creator><creator>FEDDER, Donald O</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>2004</creationdate><title>Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: A preliminary report</title><author>KORO, Carol E ; BOWLIN, Steven J ; BOURGEOIS, Nancy ; FEDDER, Donald O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g314t-69884ce3be3cfff9120c63c3d9531ba227d86291bba47194bebf70e1bdf848a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Administration, Oral</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Blood Glucose - metabolism</topic><topic>Care and treatment</topic><topic>Demographic aspects</topic><topic>Demography</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Diabetes Mellitus, Type 2 - therapy</topic><topic>Diabetes therapy</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Diet, Diabetic</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Ethnic Groups</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Evaluation</topic><topic>Health Surveys</topic><topic>Humans</topic><topic>Hypoglycemic Agents - administration & dosage</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Insulin - therapeutic use</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Risk Factors</topic><topic>Type 2 diabetes</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KORO, Carol E</creatorcontrib><creatorcontrib>BOWLIN, Steven J</creatorcontrib><creatorcontrib>BOURGEOIS, Nancy</creatorcontrib><creatorcontrib>FEDDER, Donald O</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KORO, Carol E</au><au>BOWLIN, Steven J</au><au>BOURGEOIS, Nancy</au><au>FEDDER, Donald O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: A preliminary report</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2004</date><risdate>2004</risdate><volume>27</volume><issue>1</issue><spage>17</spage><epage>20</epage><pages>17-20</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><coden>DICAD2</coden><abstract>To describe the changes in demographics, antidiabetic treatment, and glycemic control among the prevalent U.S. adult diagnosed type 2 diabetes population between the National Health and Nutrition Examination Survey (NHANES) III (1988-1994) and the initial release of NHANES 1999-2000.
The study population was derived from NHANES III (n = 1,215) and NHANES 1999-2000 (n = 372) subjects who reported a diagnosis of type 2 diabetes with available data on diabetes medication and HbA(1c). Four therapeutic regimens were defined: diet only, insulin only, oral antidiabetic drugs (OADs) only, or OADs plus insulin. Multiple logistic regression was used to examine changes in antidiabetic regimens and glycemic control rates over time, adjusted for demographic and clinical risk factors. The outcome measure for glycemic control was HbA(1c). Glycemic control rates were defined as the proportion of type 2 diabetic patients with HbA(1c) level <7%.
Dietary treatment in individuals with diabetes decreased as the sole therapy from 27.4 to 20.2% between the surveys. Insulin use also decreased from 24.2 to 16.4%, while those on OADs only increased from 45.4 to 52.5%. Combination of OADs and insulin increased from 3.1 to 11.0%. Glycemic control rates declined from 44.5% in NHANES III (1988-1994) to 35.8% in NHANES 1999-2000.
Treatment regimens among U.S. adults diagnosed with type 2 diabetes have changed substantially over the past 10 years. However, a decrease in glycemic control rates was also observed during this time period. This trend may contribute to increased rates of macrovascular and microvascular diabetic complications, which may impact health care costs. Our data support the public health message of implementation of early, aggressive management of diabetes.</abstract><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>14693960</pmid><doi>10.2337/diacare.27.1.17</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0149-5992 |
| ispartof | Diabetes care, 2004, Vol.27 (1), p.17-20 |
| issn | 0149-5992 1935-5548 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_80071790 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Administration, Oral Adult Aged Biological and medical sciences Blood Glucose - metabolism Care and treatment Demographic aspects Demography Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - epidemiology Diabetes Mellitus, Type 2 - therapy Diabetes therapy Diabetes. Impaired glucose tolerance Diet, Diabetic Endocrine pancreas. Apud cells (diseases) Endocrinopathies Ethnic Groups Etiopathogenesis. Screening. Investigations. Target tissue resistance Evaluation Health Surveys Humans Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - therapeutic use Insulin - therapeutic use Medical sciences Middle Aged Risk Factors Type 2 diabetes United States |
| title | Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: A preliminary report |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T04%3A42%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glycemic%20control%20from%201988%20to%202000%20among%20U.S.%20adults%20diagnosed%20with%20type%202%20diabetes:%20A%20preliminary%20report&rft.jtitle=Diabetes%20care&rft.au=KORO,%20Carol%20E&rft.date=2004&rft.volume=27&rft.issue=1&rft.spage=17&rft.epage=20&rft.pages=17-20&rft.issn=0149-5992&rft.eissn=1935-5548&rft.coden=DICAD2&rft_id=info:doi/10.2337/diacare.27.1.17&rft_dat=%3Cgale_proqu%3EA112312321%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80071790&rft_id=info:pmid/14693960&rft_galeid=A112312321&rfr_iscdi=true |